Table 1. Sequencing, assembly and annotations summaries.
A. Sequencing and preprocessing | ||||
Sampled Conditions | Non Infected | V. parahemolyticus infected | ||
No of Samples | 6 | 4 | ||
Sequencing Technology | Hi-seq | Mi-seq | ||
No of Raw Reads | 361,633,550 | 100% | 135,621,610 | 100% |
Total no of Raw Bases | 36,524,988,550 | 100% | 36,234,206,749 | 100% |
No of Clean Reads | 345,408,880 | 96% | 127,493,803 | 94% |
Total no of clean Bases | 34,332,144,915 | 94% | 30,248,043,590 | 83% |
B. Assembly (De novo) | ||||
No of Transcripts | 97,828 | |||
Total Bases | 138,588,672 | |||
Length Range (Min-Max) | 500 to 29,122 | |||
Mapped Reads by Reference Mapping | 117,499,227 | 91% | ||
Mapped Bases by Reference Mapping | 26,508,379,523 | 87% | ||
C. Annotations | ||||
Blast | 43,843 | 45% | ||
Gene Ontology | 23,560 | 24% | ||
KEGG | 3,337 | 3% |